Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP | BSE: 508869) has officially transitioned its subsidiary, Apollo Health and Lifestyle Limited (AHLL), into a wholly-owned entity. In a regulatory filing dated April 10, 2026, the healthcare giant announced the acquisition of the remaining minority stake from individual shareholders, marking the final step in a consolidation process that began in 2025.
The Final Stake Acquisition
Following the previous buyout of institutional stakes held by the International Finance Corporation (IFC) and IFC EAF, Apollo Hospitals has now acquired an additional 775,744 equity shares from existing individual shareholders.
The transaction details are as follows:
Purchase Price: ₹241 per share.
Total Consideration: Approximately ₹18.69 crore.
Final Result: This acquisition moves the company's shareholding in AHLL from 99.42% to a full 100%.
Strategic Consolidation of AHLL
Apollo Health and Lifestyle Limited is the retail healthcare arm of the group, managing a vast network of primary care clinics, diagnostic centers (Apollo Diagnostics), cradles, and specialty surgery centers (Apollo Spectra). By moving to 100% ownership, Apollo Hospitals gains absolute operational control and simplifies the corporate structure of its retail healthcare business.
This move allows for seamless integration of AHLL's diagnostic and clinic networks with the broader hospital ecosystem and the "Apollo 24|7" digital platform. The consolidation is expected to improve financial synergies and accelerate decision-making across the retail healthcare vertical.
Shares of Apollo Hospitals Enterprise Limited was last trading in BSE at Rs. 7514.70 as compared to the previous close of Rs. 7480.25. The total number of shares traded during the day was 15099 in over 2545 trades.
The stock hit an intraday high of Rs. 7563.00 and intraday low of 7466.00. The net turnover during the day was Rs. 113777662.00.